Cholangiocarcinoma Foundation

Analysis

Cholangiocarcinoma Foundation is a registered charity in United States, based in Salt Lake City, UT. It received its IRS tax-exemption ruling in November 2007, 19 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Cholangiocarcinoma Foundation reported income of $5.1m and spending of $5.3m, spending 104% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $2.2m to $5.1m (+130%), an average of +23% a year. The sharpest change came in the year to June 2021, when income rose by 107%. Over the whole period it spent 83% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cholangiocarcinoma Foundation sits at the 79th percentile: it is larger than about 79% of them. Against every charity in United States with reported income it ranks in the 92nd percentile, and in the 92nd percentile within UT. Charities of a similar size with the same main cause include Hillcrest Washington Youth Home Inc ($5.1m), Lutheran Care Center ($5.1m) and Huther-Doyle Memorial Institute Inc ($5.1m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 96% and program service revenue 1.2% of the total. Compensation of current officers, directors and key employees was $340k (6.5% of expenses). Other salaries and wages came to $1.5m. At year end it held assets of $4.6m against liabilities of $993k, net assets of $3.6m. It reported 26 employees.